CervoMed Inc

Ticker CRVO

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

1-10 Employees
Based in Boston, Massachusetts

CervoMed is a public, Boston, MA-based company advancing CNS-focused therapeutics to benefit patients with neurodegenerative diseases. CervoMed was launched in 2014 as EIP Pharma, Inc, by R&D executives from the pharmaceutical and biotech industry. In August, 2023 EIP Pharma merged with Diffusion Pharmaceuticals, retaining EIP’s development pipeline, but changing their name to CervoMed (CRVO).

Visit website

REPORT RATINGS

4.8 / 5.0 (146)

CervoMed Inc reports have an aggregate usefulness score of 4.8 based on 146 reviews.

CervoMed Inc